WATWaters Corporation

Healthcare

$433.70+42% 1Y

$433.70

$283.3252 weeks$443.32

Price

+42%1Y

End-of-day closes, not the intraday tick.

A mixed picture: the questions disagree

Quality mixed, no red flags, demanding price, growth steady, the market undecided.

RyuScore 49 of 100: see how it is built

What they do

The Company’s products are used by pharmaceutical, clinical, biochemical, industrial, nutritional safety, environmental, academic and governmental customers working in research and development, quality assurance and other laboratory applications. LC is a standard technique and is utilized in a broad range of industries to detect, identify, monitor and measure the chemical, physical and biological composition of materials, and to purify a full range of compounds.

In the company’s own words · 10-K filed Feb 23, 2026 · SEC EDGAR

P/E108.2

Market value$34.90B

1 year+42%

5 years+7.6%

Charts

As reported to the SEC, without any scoring.

Waters Corporation (WAT) reported revenue of $1.65B in Q2 2026 (quarter ended Jul 4, 2026), up 113% from the same quarter a year earlier. That came with net loss of $136M. For the full year FY2025, revenue was $3.17B (+7.0% year on year) and net income $643M. Its largest product in Q2 2026 was Consumables at $765M, 47% of the disclosed total, ahead of Instrument Systems at 28%. The next results filing is expected around Nov 3, 2026, the same week as a year ago.

What the company said

The company's own words from its current reports to the SEC, newest first

Aug 21, 2026On August 17, 2026, Robert L. Carpio III notified Waters Corporation (the “Company”) of his decision to resign from his position as Senior Vice President, Waters Analytical Sciences Division to pursue other opportunities.Director or officer change · Form 8-K
Aug 4, 2026Relations – (508) 482-3448.Earnings release · press release
May 5, 2026Head of Investor Relations – (508) 482-3448.Earnings release · press release